Summary
Nexstim Plc (Nexstim), a medical technology company that develops, manufactures and commercializes non-invasive brain stimulation technologies and devices to treat patients suffering from depressive disorders and chronic pain. The company provides Navigated Brain Therapy (NBT) system for the treatment of major depression disorder (MDD) and chronic neuropathic pain and Navigated Brain Stimulation (NBS) system for pre-surgical diagnostics. The company also develops products based on its proprietary SmartFocus TMS technology. Nexstim offers its products primarily to leading hospitals and universities through direct sales and distributors in the US, Europe, and Asia. The company has operations in Finland, Germany, and the US. Nexstim is headquartered in Helsinki, Finland
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook